JP2007509186A5 - - Google Patents

Download PDF

Info

Publication number
JP2007509186A5
JP2007509186A5 JP2006537550A JP2006537550A JP2007509186A5 JP 2007509186 A5 JP2007509186 A5 JP 2007509186A5 JP 2006537550 A JP2006537550 A JP 2006537550A JP 2006537550 A JP2006537550 A JP 2006537550A JP 2007509186 A5 JP2007509186 A5 JP 2007509186A5
Authority
JP
Japan
Prior art keywords
ache
inhibitor
use according
expression
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006537550A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007509186A (ja
JP4753088B2 (ja
Filing date
Publication date
Priority claimed from IL158600A external-priority patent/IL158600A/en
Application filed filed Critical
Publication of JP2007509186A publication Critical patent/JP2007509186A/ja
Publication of JP2007509186A5 publication Critical patent/JP2007509186A5/ja
Application granted granted Critical
Publication of JP4753088B2 publication Critical patent/JP4753088B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006537550A 2003-10-26 2004-10-26 抗炎症薬としてのAChEアンチセンスデオキシオリゴヌクレオチド Expired - Fee Related JP4753088B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL158600A IL158600A (en) 2003-10-26 2003-10-26 Dioxysoligonucleotide Antisense Against Acetylcholinesterase as an Anti-Inflammatory Agent
IL158600 2003-10-26
PCT/IL2004/000978 WO2005039480A2 (en) 2003-10-26 2004-10-26 AChE ANTISENSE DEOXYOLIGONUCLEOTIDE AS AN ANTI-INFLAMMATORY AGENT

Publications (3)

Publication Number Publication Date
JP2007509186A JP2007509186A (ja) 2007-04-12
JP2007509186A5 true JP2007509186A5 (enExample) 2007-12-06
JP4753088B2 JP4753088B2 (ja) 2011-08-17

Family

ID=34044237

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006537550A Expired - Fee Related JP4753088B2 (ja) 2003-10-26 2004-10-26 抗炎症薬としてのAChEアンチセンスデオキシオリゴヌクレオチド

Country Status (6)

Country Link
US (3) US20060069051A1 (enExample)
EP (2) EP1682072A4 (enExample)
JP (1) JP4753088B2 (enExample)
CA (1) CA2543305A1 (enExample)
IL (1) IL158600A (enExample)
WO (1) WO2005039480A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2007399A2 (en) * 2006-04-10 2008-12-31 Ester Neurosciences Ltd. Antisense oligonucleotides against acetylcholinesterase for treating inflammatory diseases
US20110136897A1 (en) * 2008-08-14 2011-06-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Toll-like receptor 9 agonists for the treatment of anxiety-related disorders and inflammatory disorders
MX2011011517A (es) 2009-04-29 2012-06-19 Amarin Corp Plc Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo.
CN102458109B (zh) 2009-04-29 2015-02-11 阿马里纳制药公司 稳定的药物组合物和使用其的方法
US9814733B2 (en) 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US20220102008A1 (en) * 2020-09-30 2022-03-31 Genentech, Inc. Methods and systems for placebo response modeling

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101600A (en) * 1992-04-15 2000-02-29 Yissum Res Dev Co Synthetic partially phosphorothioated antisense oligodeoxynucleotides and pharmaceutical compositions containing them
US6495579B1 (en) * 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
AU727611B2 (en) * 1996-12-12 2000-12-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
AU8742198A (en) * 1997-08-15 1999-03-08 Shire International Licensing B.V. Use of cholinesterase inhibitor for treating diseases associated with pro teolytic enzyme activity
IL143379A (en) 2001-05-24 2013-11-28 Yissum Res Dev Co Oligonucleotide against human ache isoform r and its uses
EP2007399A2 (en) * 2006-04-10 2008-12-31 Ester Neurosciences Ltd. Antisense oligonucleotides against acetylcholinesterase for treating inflammatory diseases

Similar Documents

Publication Publication Date Title
Cunningham et al. The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I: C)
Fonseca et al. Use of CpG oligonucleotides in treatment of asthma and allergic disease
G Drake et al. The therapeutic potential of Toll-like receptor 7 stimulation in asthma
WO2005067900A3 (en) Azabenzofuran substituted thioureas as inhibitors of viral replication
JP2012505837A5 (enExample)
Iauk et al. Protection against murine endotoxemia by treatment with Ruta chalepensis L., a plant with anti-inflammatory properties
Xu et al. Differential expression of pro-inflammatory and anti-inflammatory genes of layer chicken bursa after experimental infection with infectious bursal disease virus
UA92746C2 (en) Thiazole compounds and methods of use
Davis et al. The neuron-specific interleukin-1 receptor accessory protein is required for homeostatic sleep and sleep responses to influenza viral challenge in mice
JP2009504157A5 (enExample)
JP2009526751A5 (enExample)
JP2007533687A5 (enExample)
WO2009026292A1 (en) Dosing methods for treating disease
JP2009510044A5 (enExample)
JP2005537234A5 (enExample)
JP2007509186A5 (enExample)
JP2009513604A5 (enExample)
JP2004537500A5 (enExample)
JP2009500045A5 (enExample)
US20100016377A1 (en) Use of a p38 Kinase Inhibitor for Treating Psychiatric Disorders
WO2005095345A3 (en) Heteroaryl guanidines as inhibitors of viral replication
KR20120044937A (ko) 약학적 제제
KR20190089005A (ko) 에베롤리무스, 닥톨리십 또는 둘 다를 사용하여 면역 반응을 증진시키는 방법
CN101437534A (zh) 口服干扰素的广谱免疫和抗病毒基因调节作用
CN1535724B (zh) 重组人干扰素在制备预防严重性急性呼吸道综合征的药物的用途